![Katherine Stultz](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Katherine Stultz
Chief Executive Officer at
BrainXell, Inc.
Profile
Katherine Vega Stultz currently works at BrainXell, Inc., as Chief Executive Officer & Director from 2025.
Ms. Stultz also formerly worked at Ocelot Bio, Inc., as President & Chief Executive Officer, Kronos Bio, Inc., as Independent Director from 2023 to 2025, Celgene Corp., as VP-Global Project Leadership & Hematology, and Graphite Bio, Inc., as Chief Operating Officer from 2020 to 2021.
Ms. Stultz received her undergraduate degree from Cornell University.
Katherine Stultz active positions
| Companies | Position | Start |
|---|---|---|
BrainXell, Inc.
 BrainXell, Inc. Pharmaceuticals: MajorHealth Technology Develops stem cell therapy for neurological injuries and diseases | Chief Executive Officer | 2025-07-09 |
Former positions of Katherine Stultz
| Companies | Position | End |
|---|---|---|
| KRONOS BIO, INC. | Director/Board Member | 2025-06-19 |
| LENZ THERAPEUTICS, INC. | Chief Operating Officer | 2021-12-30 |
| CELGENE | Corporate Officer/Principal | 2019-12-31 |
Ocelot Bio, Inc.
 Ocelot Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals for patients with liver diseases | Chief Executive Officer | - |
Training of Katherine Stultz
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
61
1st degree connections
6
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Develops cancer and immunology drugs | Health Technology |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kronos Bio, Inc.
 Kronos Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops novel cancer therapeutics | Health Technology |
Graphite Bio, Inc.
 Graphite Bio, Inc. BiotechnologyHealth Technology Operates as gene editing company for DNA integrations | Health Technology |
Ocelot Bio, Inc.
Ocelot Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals for patients with liver diseases | Health Technology |
BrainXell, Inc.
BrainXell, Inc. Pharmaceuticals: MajorHealth Technology Develops stem cell therapy for neurological injuries and diseases | Health Technology |
- Stock Market
- Insiders
- Katherine Stultz
